173 related articles for article (PubMed ID: 36992402)
1. Prolonged SARS-CoV-2 Infection and Organizing Pneumonia in a Patient with Follicular Lymphoma, Treated with Obinutuzumab-Challenging Recognition and Treatment.
Łyżwa E; Sobiecka M; Lewandowska K; Siemion-Szcześniak I; Barańska I; Klatt M; Langfort R; Szturmowicz M; Tomkowski W
Viruses; 2023 Mar; 15(3):. PubMed ID: 36992402
[TBL] [Abstract][Full Text] [Related]
2. Persistent SARS-CoV-2 infection with multiple clinical relapses in two patients with follicular lymphoma treated with bendamustine and obinutuzumab or rituximab.
Franceschini E; Pellegrino M; Todisco V; Dolci G; Bettelli F; Meschiari M; Bedini A; Fregni-Serpini G; Grottola A; Guaraldi G; Pecorari M; Sarti M; Luppi M; Perno CF; Mussini C
Infection; 2023 Oct; 51(5):1577-1581. PubMed ID: 37076752
[TBL] [Abstract][Full Text] [Related]
3. Prolonged COVID-19 in an Immunocompromised Patient Treated with Obinutuzumab and Bendamustine for Follicular Lymphoma.
Ueda Y; Asakura S; Wada S; Saito T; Yano T
Intern Med; 2022 Aug; 61(16):2523-2526. PubMed ID: 35650124
[TBL] [Abstract][Full Text] [Related]
4. Acute acalculous cholecystitis following extended administration of nirmatrelvir/ritonavir for persistent SARS-CoV-2 infection.
Ito W; Fukumori T; Asaoka N; Imakita N; Nishimura T; Furukawa R; Nishihara Y; Fujikura H; Sekine T; Yamaguchi N; Hirata Y; Miyamoto S; Kanno T; Katano H; Suzuki T; Kasahara K
J Infect Chemother; 2024 Jul; 30(7):659-663. PubMed ID: 38184107
[TBL] [Abstract][Full Text] [Related]
5. Prolonged SARS-CoV-2 infection during obinutuzumab and bendamustine treatment for follicular lymphoma: A case report.
Kambe R; Sato M; Uehara D; Iizuka Y; Kakizaki S
Clin Case Rep; 2023 Sep; 11(9):e7861. PubMed ID: 37649899
[TBL] [Abstract][Full Text] [Related]
6. Dual Antiviral Therapy for Persistent Coronavirus Disease 2019 and Associated Organizing Pneumonia in an Immunocompromised Host.
Trottier CA; Wong B; Kohli R; Boomsma C; Magro F; Kher S; Anderlind C; Golan Y
Clin Infect Dis; 2023 Mar; 76(5):923-925. PubMed ID: 36281907
[TBL] [Abstract][Full Text] [Related]
7. Resolution of One-Year Persisting COVID-19 Pneumonia and Development of Immune Thrombocytopenia in a Follicular Lymphoma Patient With Preceding Rituximab Maintenance Therapy: A follow-up Report and Literature Review of Cases With Prolonged Infections.
Yasuda H; Mori Y; Chiba A; Bai J; Murayama G; Matsushita Y; Miyake S; Komatsu N
Clin Lymphoma Myeloma Leuk; 2021 Oct; 21(10):e810-e816. PubMed ID: 34393077
[TBL] [Abstract][Full Text] [Related]
8. Management of Persistent SARS-CoV-2 Infection in Patients with Follicular Lymphoma.
Martínez-Barranco P; García-Roa M; Trelles-Martínez R; Arribalzaga K; Velasco M; Guijarro C; Marcos J; Campelo C; Acedo-Sanz JM; Villalón L; Ricard P; García-Bueno MJ; Pérez-Fernández E; Rodríguez-Caravaca G; Peñalver FJ
Acta Haematol; 2022; 145(4):384-393. PubMed ID: 34839289
[TBL] [Abstract][Full Text] [Related]
9. A Teaching Case: Persistent COVID-19 Pneumonia Resembling Cryptogenic Organizing Pneumonia in a Patient With Remitted Lymphoma.
Yanagihara T; Kadowaki M; Otsuka J; Ishimatsu A; Taguchi K; Moriuchi Y; Ogata H; Moriwaki A; Yoshida M
Cureus; 2023 Nov; 15(11):e48319. PubMed ID: 38060718
[TBL] [Abstract][Full Text] [Related]
10. Casirivimab/Imdevimab for Active COVID-19 Pneumonia Which Persisted for Nine Months in a Patient with Follicular Lymphoma during Anti-CD20 Therapy.
Nagai H; Saito M; Adachi E; Sakai-Tagawa Y; Yamayoshi S; Kiso M; Kawamata T; Koga M; Kawaoka Y; Tsutsumi T; Yotsuyanagi H
Jpn J Infect Dis; 2022 Nov; 75(6):608-611. PubMed ID: 35768273
[TBL] [Abstract][Full Text] [Related]
11. A case of prolonged COVID-19 treated with tixagevimab/cilgavimab.
Shimizu T; Shirasaki H; Okafuji K; Sawazaki A; Iwabuchi T; Matubayashi R
Respirol Case Rep; 2023 Mar; 11(3):e01099. PubMed ID: 36789174
[TBL] [Abstract][Full Text] [Related]
12. Persistent COVID-19 Pneumonia and Failure to Develop Anti-SARS-CoV-2 Antibodies During Rituximab Maintenance Therapy for Follicular Lymphoma.
Yasuda H; Tsukune Y; Watanabe N; Sugimoto K; Uchimura A; Tateyama M; Miyashita Y; Ochi Y; Komatsu N
Clin Lymphoma Myeloma Leuk; 2020 Nov; 20(11):774-776. PubMed ID: 32933879
[No Abstract] [Full Text] [Related]
13. Prolonged viral positivity induced recurrent coronavirus disease 2019 (COVID-19) pneumonia in patients receiving anti-CD20 monoclonal antibody treatment: Case reports.
Deveci B; Saba R
Medicine (Baltimore); 2021 Dec; 100(52):e28470. PubMed ID: 34967391
[TBL] [Abstract][Full Text] [Related]
14. A 63-Year-Old Woman with a History of Non-Hodgkin Lymphoma with Persistent SARS-CoV-2 Infection Who Was Seronegative and Treated with Convalescent Plasma.
Moore JL; Ganapathiraju PV; Kurtz CP; Wainscoat B
Am J Case Rep; 2020 Oct; 21():e927812. PubMed ID: 33009361
[TBL] [Abstract][Full Text] [Related]
15. A Case of Long-Term SARS-CoV-2 Infection in a Patient with Follicular Lymphoma.
Zhang D; Zheng Z
Clin Lab; 2024 May; 70(5):. PubMed ID: 38747907
[No Abstract] [Full Text] [Related]
16. Secondary organizing pneumonia associated with protracted COVID: A case series.
Sansen PY; Coche E; Hainaut P; Froidure A; Scohy A; Ghaye B; Belkhir L; De Greef J
Infect Dis Now; 2024 Apr; 54(3):104888. PubMed ID: 38494118
[TBL] [Abstract][Full Text] [Related]
17. Hyperimmune plasma infusion in an immunocompromised Covid-19 patient previously treated for follicular lymphoma.
Levi G; Rocchetti C; Magri R; Uccelli S; Bottone D; Quadri F; Novali M; Santin AD; Bezzi M
Monaldi Arch Chest Dis; 2021 Jun; 91(4):. PubMed ID: 34121379
[TBL] [Abstract][Full Text] [Related]
18. Recurrent and persistent fever after SARS-CoV-2 infection in patients with follicular lymphoma: A case series.
Huang L; Tong X; Cui J; Du X; Liao Y; Tan X; Ju Y; Zhong X; Zhou W; Xu X; Li Y
Int J Infect Dis; 2024 Apr; 141():106973. PubMed ID: 38395220
[TBL] [Abstract][Full Text] [Related]
19. Persistent SARS-CoV-2 infection in patients with secondary antibody deficiency: successful clearance following combination casirivimab and imdevimab (REGN-COV2) monoclonal antibody therapy.
Taha Y; Wardle H; Evans AB; Hunter ER; Marr H; Osborne W; Bashton M; Smith D; Burton-Fanning S; Schmid ML; Duncan CJA
Ann Clin Microbiol Antimicrob; 2021 Dec; 20(1):85. PubMed ID: 34969393
[TBL] [Abstract][Full Text] [Related]
20. Prolonged
Papanikolopoulou A; Thimis V; Antonogiannaki E; Rapti V; Tsiakos K; Krallis G; Ntouraki S; Kokkotis G; Panagiotou E; Sakka V; Kakalou E; Nitsotolis T; Poulakou G; Syrigos KN
In Vivo; 2023; 37(1):461-467. PubMed ID: 36593037
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
